PKC-α regulates cardiac contractility and propensity toward heart failure

Nature Medicine

Volumn 10, Issue 3, 2004, Pages 248-254

  Braz, Julian C ^a,b   Gregory, Kimberly ^b   Pathak, Anand ^b   Zhao, Wen ^b   Sahin, Bogachan ^c   Klevitsky, Raisa ^a   Kimball, Thomas F ^a   Lorenz, John N ^b   Nairn, Angus C ^d   Liggett, Stephen B ^b   Bodi, Ilona ^b   Wang, Su ^e   Schwartz, Arnold ^b   Lakatta, Edward G ^e   DePaoli Roach, Anna A ^f   Robbins, Jeffrey ^a   Hewett, Timothy E ^a   Bibb, James A ^c   Westfall, Margaret V ^g   Kranias, Evangelia G ^b   Molkentin, Jeffery D ^a   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; CALCIUM; LIM PROTEIN; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN SERINE THREONINE KINASE; CALCIUM BINDING PROTEIN; CALSEQUESTRIN; ISOENZYME; PHOSPHOPROTEIN PHOSPHATASE; PRKCA PROTEIN, MOUSE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEPHOSPHORYLATION; GENE DELETION; GENE OVEREXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CARDIOMYOPATHY; CYTOLOGY; DRUG ANTAGONISM; FORWARD HEART FAILURE; GENETICS; HEART CONTRACTION; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RISK FACTOR;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CALSEQUESTRIN; CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; ISOENZYMES; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RATS; RISK FACTORS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 1642388834     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1000     Document Type: Article

References (31)

1. Dempsey, E.C. et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Mol. Physiol. 279, L429-L438 (2000).
2. Pass, J.M. et al. Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced heart failure: a role for RACK1. Am. J. Physiol. Heart Circ. Physiol. 281, H2500-H2510 (2001).
3. Ping, P. et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81, 404-414 (1997).
4. MacLennan, D.H. & Kranias, E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566-577 (2003).
5. MacDougall, L.K., Jones, L.R. & Cohen, P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196, 725-734 (1991).
6. Steenaart, N.A., Ganim, J.R., Di Salvo, J. & Kranias, E.G. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch. Biochem. Biophys. 293, 17-24 (1992).
7. 2+ movement. Basic Res. Cardiol. 97, 191-195 (2002).
8. Bayer, A.L. et al. Alterations in protein kinase C isoenzyme expression and autophosphorylation during progression of pressure overload-induced left ventricular hypertrophy. Mol. Cell. Biochem. 242, 145-152 (2003).
9. Bowling, N. et al. Increased protein kinase C activity and expression of calcium-sensitive isoforms in the failing human heart. Circulation 99, 384-391 (1999).
10. Wang, J., Liu, X., Sentex, E., Takeda, N. & Dhalla, N.S. Increased expression of protein kinase C isoforms in heart failure due to myocardiai infarction. Am. J. Physiol. Heart Circ. Physiol. 284, H2277-H2287 (2003).
11. Carr, A.N. et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22, 4124-4135 (2002).
12. El-Armouche, A. et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes. FASEB J. 17, 437-439 (2003).
13. Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403 (1997).
14. Bibb, J.A. et al. Phosphorylation of the protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276, 14490-14497 (2001).
15. Hubbard, M.J., Dent, P., Smythe, C. & Cohen, P. Targeting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen. Eur. J. Biochem. 189, 243-249 (1990).
16. Champion, H.C. et al. Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to the study of phospholamban physiology. Circulation 108, 2790-2797 (2003).
17. Klein, L. et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am. J. Cardiol. 91, 18F-40F (2003).
18. Minamisawa, S. et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313-322 (1999).
19. Hoshijima, M. et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864-871 (2002).
20. Warner-Stevenson, L. Clinical use of inotropic therapy for heart failure: looking backward or forward? Circulation 108, 492-497 (2003).
21. Bristow, M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation 101, 558-569 (2000).
22. Hahn, H.S. et al. Protein kinase Cα negatively regulates systolic and diastolic function in pathological hypertrophy. Circ. Res. 93, 1111-1119 (2003).
23. Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 7, 393-403 (1997).
24. Liang, Q. et al. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J. 22, 5079-5089 (2003).
25. Bueno, O.F. et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341-6350 (2000).
26. Westfall, M.V. & Borton, A.R. Role of troponin I phosphorylation in protein kinase C-mediated enhanced contractile performance of rat myocytes. J. Biol. Chem. 278, 33694-33700 (2003).
27. Petrashevskaya, N.N., Bodi, I., Rubio, M., Molkentin, J.D. & Schwartz, A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc. Res. 54, 117-132 (2002).
28. 2+ channels in mouse ventricular myocytes. Am. J. Physiol. 272, H606-H612 (1997).
29. Chu, G. et al. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 79, 1064-1076 (1996).
30. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 275, 13571-13579 (2000).
31. Braz, J.C., Bueno, O.F., De Windt, L.J. & Molkentin, J.D. PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase 1/2 (ERK1/2). J. Cell. Biol. 156, 905-919 (2002).